Sign in

CIK 0001367644 · Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
141902018
Phone
240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$145,792
in 2 filings, $146K under 10b5-1 plans

Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. DeGolyer Donald W −$126K Director sold 14% of stake
  2. Williams Paul Anthony −$20K SVP, Products Business sold 2% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-25 Zoon Kathryn C Director Grant or award +33,847 53,501
2023-05-25 White Marvin L Director Grant or award +33,847 50,949
2023-05-25 Hauer Jerome M Director Grant or award +33,847 57,508
2023-05-25 SULLIVAN LOUIS W Director Grant or award +33,847 87,265
2023-05-25 Richard Ronald Director Grant or award +33,847 53,684
2023-05-25 Katkin Keith Director Grant or award +33,847 42,442
2023-05-25 Harsanyi Zsolt Chairman Grant or award +33,847 71,899
2023-05-25 Dayal Sujata Tyagi Director Grant or award +33,847 45,699
2023-04-07 Glessner Coleen EVP, Quality & Ethics, and CPL Shares withheld for taxes +480 120,154
2023-03-02 Havey Adam EVP, Business Operations Grant or award +6,154 88,243
2023-03-02 Havey Adam EVP, Business Operations Grant or award +12,308 100,551
2023-03-02 Havey Adam EVP, Business Operations Grant or award · Employee Stock Options (Right to Buy) +12,308 112,675
2023-03-02 Kramer Robert President and CEO Grant or award +19,231 255,289
2023-03-02 Kramer Robert President and CEO Grant or award +38,462 293,751
2023-03-02 Kramer Robert President and CEO Grant or award · Employee Stock Options (Right to Buy) +38,462 258,182
2023-03-02 Glessner Coleen EVP, Quality & Ethics, and CPL Grant or award +3,846 111,982
2023-03-02 Glessner Coleen EVP, Quality & Ethics, and CPL Grant or award +7,692 119,674
2023-03-02 Glessner Coleen EVP, Quality & Ethics, and CPL Grant or award · Employee Stock Options (Right to Buy) +7,692 31,343
2023-03-02 Williams Paul Anthony SVP, Products Business Grant or award +1,154 10,070
2023-03-02 Williams Paul Anthony SVP, Products Business Grant or award +2,308 12,378

Page 12 of 17 · 330 trades